• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mBio . A Multitrait Locus Regulates Sarbecovirus Pathogenesis

tetano

Editor, Senior Moderator
mBio


. 2022 Jul 12;e0145422.
doi: 10.1128/mbio.01454-22. Online ahead of print.
A Multitrait Locus Regulates Sarbecovirus Pathogenesis


Alexandra Schäfer[SUP] 1 [/SUP], Sarah R Leist[SUP] 1 [/SUP], Lisa E Gralinski[SUP] 1 [/SUP], David R Martinez[SUP] 1 [/SUP], Emma S Winkler[SUP] 2 3 [/SUP], Kenichi Okuda[SUP] 4 [/SUP], Padraig E Hawkins[SUP] 4 [/SUP], Kendra L Gully[SUP] 1 [/SUP], Rachel L Graham[SUP] 1 [/SUP], D Trevor Scobey[SUP] 1 [/SUP], Timothy A Bell[SUP] 5 [/SUP], Pablo Hock[SUP] 5 [/SUP], Ginger D Shaw[SUP] 5 6 [/SUP], Jennifer F Loome[SUP] 7 8 [/SUP], Emily A Madden[SUP] 7 [/SUP], Elizabeth Anderson[SUP] 9 8 [/SUP], Victoria K Baxter[SUP] 9 8 [/SUP], Sharon A Taft-Benz[SUP] 5 8 [/SUP], Mark R Zweigart[SUP] 1 [/SUP], Samantha R May[SUP] 1 [/SUP], Stephanie Dong[SUP] 1 [/SUP], Matthew Clark[SUP] 7 [/SUP], Darla R Miller[SUP] 5 6 [/SUP], Rachel M Lynch[SUP] 5 6 [/SUP], Mark T Heise[SUP] 5 7 8 [/SUP], Roland Tisch[SUP] 7 [/SUP], Richard C Boucher[SUP] 4 [/SUP], Fernando Pardo Manuel de Villena[SUP] 5 [/SUP], Stephanie A Montgomery[SUP] 9 6 [/SUP], Michael S Diamond[SUP] 2 3 10 [/SUP], Martin T Ferris[SUP] 5 [/SUP], Ralph S Baric[SUP] 1 7 6 8 [/SUP]



Affiliations

Abstract

Infectious diseases have shaped the human population genetic structure, and genetic variation influences the susceptibility to many viral diseases. However, a variety of challenges have made the implementation of traditional human Genome-wide Association Studies (GWAS) approaches to study these infectious outcomes challenging. In contrast, mouse models of infectious diseases provide an experimental control and precision, which facilitates analyses and mechanistic studies of the role of genetic variation on infection. Here we use a genetic mapping cross between two distinct Collaborative Cross mouse strains with respect to severe acute respiratory syndrome coronavirus (SARS-CoV) disease outcomes. We find several loci control differential disease outcome for a variety of traits in the context of SARS-CoV infection. Importantly, we identify a locus on mouse chromosome 9 that shows conserved synteny with a human GWAS locus for SARS-CoV-2 severe disease. We follow-up and confirm a role for this locus, and identify two candidate genes, CCR9 and CXCR6, that both play a key role in regulating the severity of SARS-CoV, SARS-CoV-2, and a distantly related bat sarbecovirus disease outcomes. As such we provide a template for using experimental mouse crosses to identify and characterize multitrait loci that regulate pathogenic infectious outcomes across species. IMPORTANCE Host genetic variation is an important determinant that predicts disease outcomes following infection. In the setting of highly pathogenic coronavirus infections genetic determinants underlying host susceptibility and mortality remain unclear. To elucidate the role of host genetic variation on sarbecovirus pathogenesis and disease outcomes, we utilized the Collaborative Cross (CC) mouse genetic reference population as a model to identify susceptibility alleles to SARS-CoV and SARS-CoV-2 infections. Our findings reveal that a multitrait loci found in chromosome 9 is an important regulator of sarbecovirus pathogenesis in mice. Within this locus, we identified and validated CCR9 and CXCR6 as important regulators of host disease outcomes. Specifically, both CCR9 and CXCR6 are protective against severe SARS-CoV, SARS-CoV-2, and SARS-related HKU3 virus disease in mice. This chromosome 9 multitrait locus may be important to help identify genes that regulate coronavirus disease outcomes in humans.

Keywords: SARS-CoV-2; collaborative cross; host response; pathogenesis; sarbecoviruses.
 
Back
Top Bottom